MedTrace Logo

Open Label, Healthy Volunteers, ADME Study With Single Oral Administration of [14C] AZD5069

NCT01332903 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2015-06-25

No results posted yet for this study

Summary

This is a phase I, open label, healthy volunteers, ADME study with single oral administration of \[14C\] AZD5069.

Conditions

  • Healthy

Interventions

DRUG

[14C] AZD5069

Single 120 mg oral dose administered on Day 1

Sponsors & Collaborators

Principal Investigators

  • Prof. Tim Mant, FRCP, FFPM · Quintiles Drug Research Unit at Guy's Hospital

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01332903 on ClinicalTrials.gov